Global Wealth Strategies & Associates’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-219
Closed -$13.7K 146
2026
Q1
$13.7K Buy
219
+19
+10% +$1.52K ﹤0.01% 286
2025
Q4
$19.1K Sell
200
-59
-23% -$5.78K ﹤0.01% 242
2025
Q3
$25.3K Sell
259
-25
-9% -$2.59K 0.01% 203
2025
Q2
$30.5K Hold
284
0.01% 140
2025
Q1
$28.6K Sell
284
-25
-8% -$2.52K 0.01% 156
2024
Q4
$27.6K Buy
309
+250
+424% +$22K 0.01% 142
2024
Q3
$4.94K Buy
+59
New +$4.65K ﹤0.01% 243

Other funds holding BSX

Global Wealth Strategies & Associates's BSX Position: Q2 2026 in Review

Global Wealth Strategies & Associates sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 219 shares — an estimated $13.7K sold.

Global Wealth Strategies & Associates first reported a position in BSX in Q3 2024 and held it in 7 quarters. The position peaked at $30.5K in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Global Wealth Strategies & Associates reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Global Wealth Strategies & Associates sold 219 Boston Scientific shares in Q2 2026, an estimated $13.7K.
  • Global Wealth Strategies & Associates first reported a position in Boston Scientific in Q3 2024 and held it in 7 quarters.
  • Global Wealth Strategies & Associates's Boston Scientific position peaked at $30.5K in Q2 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Global Wealth Strategies & Associates's 13F filing for Q2 2026, filed 1 Jul 2026.